Type of Study:
The purpose of this study is evaluating Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive in Premenopausal Females Aged 18 to 35 Years (Inclusive).

Study Length:
14 Months

Target Age/Sex:
18 - 35 years old - Female

Benefits:
Participants will receive at no cost: medication and any other study related procedures. Subject will also receive a stipend for time/travel related to the study.

Link: ClinicalTrials.gov

Staus: Enrolling

Description:

Potential participants must be sexually active and engage in heterosexual vaginal intercourse at least once per month with a partner who is not known to be subfertile, sterilized, or infertile, and should not routinely use any other form of contraception.

Enroll Now

Enroll Now